Clinical Trials in Cleveland

Showing 1561-1580 of 16,969 trials

Triathlon All-Polyethylene Tibia Outcomes Study

NCT04636190

The purpose of this study is to evaluate the clinical functional results of the Triathlon All-Polyethylene Tibia Knee Device.

Arthropathy of KneeReplacementKnee Arthritis

Stryker Orthopaedics204 participantsStarted Jul 2021

Lansing, Michigan, United States • Buffalo, New York, United States • Syracuse, New York, United States +3 more locations

Active Not RecruitingPhase 1< 1 mile

AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma

NCT03434769

The purpose of this study is to determine if it is possible to treat your cancer with a new type of T cell-based immunotherapy (therapy that uses your immune system to treat the cancer). T cells are a type of white blood cell that helps the body fight infections. This treatment uses T cells already present within your body that have been modified outside of the body and returned to target your cancer. This type of treatment is sometimes referred to as adoptive cell transfer (ACT). In this study the specific type of cells that will be used is called chimeric antigen receptor T cells (CAR T cells). Another purpose of this study is to learn about the side effects and toxicities related to this treatment.

Non-Hodgkin Lymphoma

Benjamin Tomlinson31 participantsStarted Jul 2018

St Louis, Missouri, United States • Cleveland, Ohio, United States

Triathlon All-Polyethylene Tibia Outcomes Study

AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma

Find Trials by Condition in Cleveland

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

A RCT to Determine the Effect of ENDS Flavor Availability on Abstinence Within Smokers

A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Open-Label Extension of EryDex Study IEDAT-04-2022

Study of INKmune in Patients With mCRPC (CaRe Prostate)

A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis